{"id":37611,"date":"2016-10-07T05:44:54","date_gmt":"2016-10-07T09:44:54","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=37611"},"modified":"2016-10-07T05:44:54","modified_gmt":"2016-10-07T09:44:54","slug":"owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611","title":{"rendered":"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)<\/strong> has been quickly moving up following an announcement from the company on September 30, stating that it had signed an agreement with Medmar LLC, for $300,000. OWCP stated that it plans to use the funds for the development of its proprietary psoriasis cream. In return, Medmar would have exclusive rights for the production, manufacturing, promotion and marketing of all OWC products, licensed across the US.<\/p>\n<p style=\"text-align: justify;\">The company noted that the loan from Medmar is non-interest bearing and would be paid for by the royalties, generated through the sale of OWCP products through Medmar. Steve Weinstein, the CEO of Medmar, stated that his company was anxious to market cannabis based medications in the US, but has been significantly limited to develop such medications, following the strict regulations. He was of the opinion that the environment in Israel, where OWCP is based, is more favorable, which allows OWC to truly undertake a clinical approach.<\/p>\n<p style=\"text-align: justify;\">The CEO of OWCP, Mordechai Bignitz, expressed his excitement at the agreement and claimed that this reflected Medmar\u2019s confidence in the commercial potential of their products. He also stated that the company was making significant progress with its clinical trials for myeloma and fibromyalgia, in addition to psoriasis. Further details of the agreement reveal that Medmar would be providing the loan in six installments, of $50,000 each, with first and second installment released on September 22 and October 1, respectively. The remainder would be delivered on the first of every month, until February, 2017.<\/p>\n<p style=\"text-align: justify;\">The agreement comes at a crucial time for both companies, as the November elections draw closer. Several analysts already believe that the elections would soon result in a second green rush, with several new candidates taking the lead. In its latest financial statements, filed on August 29, OWC indicated that it had a cash position of just over $162,000 and its convertible debt had climbed by $48,000, over the six months period, ended June 30, 2016.<\/p>\n<p style=\"text-align: justify;\">OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) closed at a share price of $0.0685, at the end of the October 6 trading session, 55.68% higher than the session before, on a trade volume of 33.88 million.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has been quickly moving up following an announcement from the company on September 30, stating that it had signed an [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":37612,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12121,12120,12119,12118],"stock_ticker":[],"class_list":["post-37611","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-mordechai-bignitz","tag-otcmktsowcp","tag-owc-pharmaceutical-research-corp","tag-owc-pharmaceutical-research-corp-otcmktsowcp","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has been quickly moving up following an announcement from the company on September 30, stating that it had signed an [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-07T09:44:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan\",\"datePublished\":\"2016-10-07T09:44:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611\"},\"wordCount\":359,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg\",\"keywords\":[\"Mordechai Bignitz\",\"OTCMKTS:OWCP\",\"OWC Pharmaceutical Research Corp\",\"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611\",\"name\":\"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg\",\"datePublished\":\"2016-10-07T09:44:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg\",\"width\":1000,\"height\":540},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611","og_locale":"en_US","og_type":"article","og_title":"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan - Wall Street PR","og_description":"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has been quickly moving up following an announcement from the company on September 30, stating that it had signed an [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2016-10-07T09:44:54+00:00","og_image":[{"width":1000,"height":540,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan","datePublished":"2016-10-07T09:44:54+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611"},"wordCount":359,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg","keywords":["Mordechai Bignitz","OTCMKTS:OWCP","OWC Pharmaceutical Research Corp","OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611","url":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611","name":"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg","datePublished":"2016-10-07T09:44:54+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/10\/OWC-Pharmaceutical-Research.jpg","width":1000,"height":540},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/owc-pharmaceutical-research-corp-otcmktsowcp-acquires-300000-non-interest-bearing-loan-37611#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Acquires $300,000 Non-Interest Bearing Loan"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=37611"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37611\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/37612"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=37611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=37611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=37611"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=37611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}